Considerations and strategies to reduce hypoglycaemia in home-dwelling older people with insulin-treated type 2 diabetes—A case study.
According to the Australian Institute of Health and Welfare (AIHW),in 2021 the incidence of diabetes in Australia increased...
Hybrid Closed Loop Technology – an update on current systems available in Australia
According to the National Diabetes Services Scheme (NDSS), over 134,000 people in Australia were registered with having type 1...
FreeStyle Libre Flash glucose monitoring in someone living with Type 3C diabetes
Type 3c diabetes (also called pancreatogenic diabetes) is caused by disruption to the structure or physiology of the pancreas through pancreatitis,...
Co-occurring Eating Disordered Behaviours with Type 1 Diabetes – complex, common, and concerning!
This article aims to increase health professionals’ awareness of type 1 diabetes (T1D) with concurrent disordered...
Escalation of diabetes therapeutic technology to improve glycaemia and quality of life: A case from the ORACL trial
Older adults with long-duration type 1 diabetes (T1D) can have additional health challenges to those experienced by...
Case study: Treatment Induced Neuropathy of Diabetes after rapid improvement in glycaemia following new diagnosis of autoimmune diabetes
Treatment Induced Neuropathy of Diabetes (TIND), also known as insulin neuritis, was first described in...
Intensive insulin therapy for children in early primary school: The narratives of parents, school teachers and diabetes educators
The number of early primary school (EPS) children (aged 4–8 years) with type 1 diabetes (T1D) rises each year.1 The current recommended...
Starting Insulin: supporting informed decision making among adults with type 2 diabetes
Long-term outcomes are improved, and complications are reduced among people with type 2 diabetes (T2D) when blood glucose levels are maintained within...